Research Output per year
Fingerprint Dive into the research topics where Yojiro Arinobu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 18 Similar Profiles
Hematopoietic Stem Cells
Medicine & Life Sciences
Interleukin-4
Medicine & Life Sciences
Systemic Lupus Erythematosus
Medicine & Life Sciences
Monocytes
Medicine & Life Sciences
Mast Cells
Medicine & Life Sciences
Interleukin-10
Medicine & Life Sciences
B-Lymphocytes
Medicine & Life Sciences
Hematopoiesis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1997 2019
2
Citations
(Scopus)
Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?
Tada, Y., Inokuchi, S., Maruyama, A., Suematsu, R., Sakai, M., Sadanaga, Y., Ono, N., Arinobu, Y. & Koarada, S., Jan 18 2019, In : Rheumatology International. 39, 1, p. 97-104 8 p.Research output: Contribution to journal › Article
Macrophage Activation Syndrome
Adult-Onset Still's Disease
Juvenile Arthritis
Sensitivity and Specificity
Triglycerides
CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines
Takaki-Kuwahara, A., Arinobu, Y., Miyawaki, K., Yamada, H., Tsuzuki, H., Irino, K., Ayano, M., kimoto, Y., Mitoma, H., Akahoshi, M., Tsukamoto, H., Horiuchi, T., Niiro, H. & Akashi, K., Aug 30 2019, In : Arthritis Research and Therapy. 21, 1, 198.Research output: Contribution to journal › Article
Open Access
Rheumatoid Arthritis
Joints
Lymphocytes
Cytokines
Synovial Fluid
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: A post hoc analysis of a phase I/II clinical trial conducted in Japan
Ayano, M., Tsukamoto, H., Mitoma, H., kimoto, Y., Akahoshi, M., Arinobu, Y., Miyamoto, T., Horiuchi, T., Niiro, H., Nagafuji, K., Harada, M. & Akashi, K., Jan 22 2019, In : Arthritis Research and Therapy. 21, 1, 30.Research output: Contribution to journal › Article
Phase II Clinical Trials
Clinical Trials, Phase I
Systemic Scleroderma
Hematopoietic Stem Cell Transplantation
Japan
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis
Fukui, S., Kuwahara-Takaki, A., Ono, N., Sato, S., Koga, T., Kawashiri, S. Y., Iwanaga, N., Iwamoto, N., Ichinose, K., Tamai, M., Nakamura, H., Origuchi, T., Migita, K., Arinobu, Y., Niiro, H., Tada, Y., Akashi, K., Maeda, T. & Kawakami, A., Dec 1 2019, In : Scientific reports. 9, 1, 688.Research output: Contribution to journal › Article
Takayasu Arteritis
Giant Cell Arteritis
Fibroblast Growth Factor 2
Granulocyte-Macrophage Colony-Stimulating Factor
Serum
5
Citations
(Scopus)
Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., Niiro, H., Akashi, K. & Horiuchi, T., Apr 1 2018, In : PloS one. 13, 4, e0196368.Research output: Contribution to journal › Article
glycohemoglobin
rheumatoid arthritis
tumor necrosis factors
Glycosylated Hemoglobin A
observational studies